Usual medical treatments or levonorgestrel-IUS for women with heavy menstrual bleeding: long-term randomised pragmatic trial in primary care.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27884916)

Published in Br J Gen Pract on October 10, 2016

Authors

Joe Kai1, Lee Middleton2, Jane Daniels2, Helen Pattison3, Konstantinos Tryposkiadis2, Janesh Gupta, ECLIPSE trial collaborative group

Author Affiliations

1: Faculty of Medicine & Health Sciences, School of Medicine, University of Nottingham, Nottingham.
2: Birmingham Clinical Trials Unit, University of Birmingham, Birmingham.
3: School of Life and Health Sciences, Aston University, Birmingham.

Articles cited by this

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer (1976) 22.55

Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis. BMJ (2002) 4.70

Levonorgestrel intrauterine system versus medical therapy for menorrhagia. N Engl J Med (2013) 2.50

Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up. JAMA (2004) 2.02

Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst Rev (2006) 1.95

The Sexual Activity Questionnaire: a measure of women's sexual functioning. Qual Life Res (1996) 1.85

Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev (2005) 1.83

Menorrhagia II: is the 80-mL blood loss criterion useful in management of complaint of menorrhagia? Am J Obstet Gynecol (2004) 1.79

Five-year follow up of women randomised to medical management or transcervical resection of the endometrium for heavy menstrual loss: clinical and quality of life outcomes. BJOG (2001) 1.61

Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data. Am J Obstet Gynecol (2004) 1.61

Perceptions of women on the impact of menorrhagia on their health using multi-attribute utility assessment. Br J Obstet Gynaecol (1998) 1.33

What aspects of periods are most bothersome for women reporting heavy menstrual bleeding? Community survey and qualitative study. BMC Womens Health (2007) 1.29

The experience of heavy menstrual bleeding: a systematic review and meta-ethnography of qualitative studies. J Adv Nurs (2008) 1.21

An epidemiological survey of symptoms of menstrual loss in the community. Br J Gen Pract (2004) 1.15

Effectiveness of a computerized decision aid in primary care on decision making and quality of life in menorrhagia: results of the MENTIP randomized controlled trial. Med Decis Making (2007) 1.13

Management of menorrhagia in primary care-impact on referral and hysterectomy: data from the Somerset Morbidity Project. J Epidemiol Community Health (2000) 1.13

Abnormal uterine bleeding: a review of patient-based outcome measures. Fertil Steril (2008) 1.03

Heavy menstrual bleeding: delivering patient-centred care. Br J Gen Pract (2008) 1.02

Host factors that influence the duration of menstrual bleeding. Epidemiology (1994) 0.87

Limited role of multi-attribute utility scale and SF-36 in predicting management outcome of heavy menstrual bleeding. Eur J Obstet Gynecol Reprod Biol (2010) 0.84

The measurement properties of the menorrhagia multi-attribute quality-of-life scale: a psychometric analysis. BJOG (2011) 0.83

The spontaneous resolution of heavy menstrual bleeding in the perimenopausal years. BJOG (2012) 0.81

Randomized placebo-controlled trial of CDB-2914 in new users of a levonorgestrel-releasing intrauterine system shows only short-lived amelioration of unscheduled bleeding. Hum Reprod (2009) 0.81

Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev (2015) 0.78